Angle’s European Ovarian Cancer Trial Enrolls First Patient

Angle’s European Ovarian Cancer Trial Enrolls First Patient
Angle PLC has recruited the first patient for its European ovarian cancer trial (ANG-001), which aims to enroll 200 women diagnosed with a pelvic mass via imaging studies who are scheduled to undergo surgery to remove their tumors. Patients’ blood will be examined with the Parsortix system, which enables the cells of interest to be acquired using a simple

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *